Novel Coronavirus (COVID-19)

Nov 19, 2020
Integer porta, ipsum eget ultrices viverra, est purus semper diam, non lobortis tortor ipsum sit amet mauris. Aenean facilisis mollis erat, vitae efficitur lacus pellentesque rhoncus.
Nov 19, 2020
Integer porta, ipsum eget ultrices viverra, est purus semper diam, non lobortis tortor ipsum sit amet mauris. Aenean facilisis mollis erat, vitae efficitur lacus pellentesque rhoncus.
Nov 19, 2020
Integer venenatis nulla eget porttitor imperdiet. Sed bibendum augue id risus ultricies mollis. Donec at augue vel nisi pulvinar ultricies.
Nov 19, 2020
Curabitur fermentum justo quam, ut ultricies dolor volutpat ac. Nunc ac tempus mi, at dapibus tortor. Donec ut sapien ultrices, ornare magna vel, porttitor turpis.
Nov 17, 2020
The recently launched AHA Living Learning Network (LLN) provides essential resources through a peer-to-peer community of health care professionals dedicated to helping hospitals and health systems recover, rebuild and reimagine health care while responding to the pandemic.
Nov 16, 2020
Moderna Inc. announced that its mRNA-1273 vaccine candidate against COVID-19 is 94.5% effective, according to early data.
Nov 16, 2020
The AHA will host a call today, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies.
Nov 13, 2020
As of Nov. 6, about 60% of the nation’s retail pharmacies have agreed to participate in a federal program to administer COVID-19 vaccines at no cost to patients once authorized or licensed by the Food and Drug Administration, the departments of Health and Human Services and Defense announced.
Nov 13, 2020
The AHA will host a call on Monday, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies.